1.
Saif M, Kaley K, Rodriguez T, Garcon M. Gemcitabine as Salvage Treatment in Patients with Poorly Differentiated Pancreatic Neuroendocrine Tumors: A Case Series. JOP [Internet]. 10Jan.2014 [cited 19Aug.2022];15(1):38-1. Available from: http://www.serena.unina.it/index.php/jop/article/view/1628